SEMA3G and Insulin resistance: In addition, Sema3G has opposing roles in adipogenesis: its plasma levels are increased in obese patients, while its deletion protects mice from HFD-induced weight and fat gain, insulin resistance and glucose tolerance and liver lipogenesis [133,134].